Tirzepatide, marketed as Zepbound for weight management, has shown higher average weight loss than semaglutide in many trial comparisons
Phase 3 trials will likely include more comprehensive metabolic panels, and it is possible that hormone endpoints will be added as exploratory outcomes
People also wondering about whether semaglutide causes blood clots or heart palpitations should discuss these concerns with their prescriber during blood work review
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
At Ocean Pacific Integrative Health Center, we can provide you with natural protocols to complement your medication to help you keep your weight loss goal with minimum side effects
[DOI] [PubMed] [Google Scholar] 82.Han L., Hlscher C., Xue G.F., Li G.L., Li D.F